undefined

Rachel Warren

Investment reporter and Motley Fool commentator focused on pharmaceutical and technology trends; offers context on deals like Pfizer–Metsera and product strategy for companies such as Peloton.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app